期刊文献+

肥胖患者体内药代动力学变化及给药方案制定 被引量:9

Formulation of dosage regimen based on pharmacokinetics in obese patients
下载PDF
导出
摘要 笔者查找近年国内外相关文献,对肥胖群体体内药物动力学变化进行综述,并对常用药物的给药方案进行评价。结果表明,肥胖患者体内药物分布和代谢均发生改变,从而导致给药剂量的变化,应根据肥胖患者的特点合理应用药物,提高治愈率,减少不良反应的发生,实现个体化给药。 The domestic and international relative articles of recent years were searched,and the changes in pharmacokinetic in obese individuals were summarized,the dosage regimen of the common-used drug was evaluated. There were changes in drug distribution and metabolismin obesity patients,which resulted in the alterations of dosage of drug. The drugs should be used rationally according to the features of the obese patients,to improve the curative rate,decrease the adverse effects and obtain the individual use of drugs.
出处 《实用药物与临床》 CAS 2015年第12期1508-1512,共5页 Practical Pharmacy and Clinical Remedies
关键词 肥胖 药代动力学 给药方案 Obesity Pharmacokinetics Dosage regimen
  • 相关文献

参考文献36

  • 1中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志,2011,27(9):711-717. 被引量:576
  • 2Mc Carron MM,Devine BJ.Clinical pharmacy:case studies case number 25 gentamicin therapy[J].Annals of Pharmacotherapy,1974,8(11):650-655.
  • 3Obesity:preventing and managing the global epidemic.World Health Organization.Report of a WHO Consultation.http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf[2009-9-29].
  • 4Blouin RA,Warren GW.Pharmacokinetic considerations in obesity[J].Journal of Pharmaceutical Sciences,1999,88(1):1-7.
  • 5Hanley MJ,Abernethy DR,Greenblatt DJ.Effect of obesity on the pharmacokinetics of drugs in humans[J].Clinical Pharmacokinetics,2010,49(2):71-87.
  • 6Abernethy DR,Greenblatt DJ.Drug disposition in obese humans[J].Clinical Pharmacokinetics,1986,11(3):199-213.
  • 7杨惠娣,施安国,安富荣.肥胖者药物动力学变化[J].中国临床药学杂志,1999,8(S1):79-81. 被引量:2
  • 8Green B,Duffull SB.What is the best size descriptor to use for pharmacokinetic studies in the obese[J].British Journal of Clinical Pharmacology,2004,58(2):119-133.
  • 9La Colla L,Albertin A,La Colla G,et al.Predictive performance of the'Minto'remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a newmethod for calculating lean body mass[J].Clinical Pharmacokinetics,2010,49(2):131-139.
  • 10Emery MG,Fisher JM,Chien JY,et al.CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease[J].Hepatology,2003,38(2):428-435.

二级参考文献25

  • 1中国肥胖问题工作组.中国成人超重和肥胖症预防控制指南(试行)2003版.
  • 2Bao Y,Lu J,Wang C,et al.Optimal waist circumference cutoffs for abdominal obesity in Chinese.Atherosclerosis,2008,201:378-384.
  • 3Dong X,Liu Y,YangJ,et al.Efficiency of anthropometric indicators of obesity for identifying cardiovascular risk factors in a Chinese population.Postgrad Med J,2011,87:251-256.
  • 4Xu F,Wang YF,Lu L,et al.Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in China's Mainland.Asia Pac J Clin Nutr,2010,19:586-593.
  • 5Shi XD,He SM,Tao YC,et al.Prevalence of obesity and associated risk factors in Northeastern China.Diabetes Res Clin Pract,2011,91:389-394.
  • 6Tsigosa C,Hainer V,Basdevant A,et al.Management of obesity in adults:European clinical practice guidelines.Obes Facts,2008,1:106-116.
  • 7The NICE Clinical Guideline CG43: Obesity: the prevention,identification,assessment and management of overweight and obesity in adults and children.www.nice.org.uk/guidance/index.jsp? action =byID&o =11000.
  • 8National Institutes of Health (NIH),National Heart,Lung,and Blood Institute (NHLBI):The practical guide:identification,evaluation,and treatment of overweight and obesity in adults.Bethesda,National Institutes of Health,2000; NIH publication 00-4084.www.nhlbi.nih.goy/guidelines/obesity/ob_home.htm.
  • 9Lau DC,Douketis JD,Morrison KM,et al.2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children[summary] .CAMJ,2007,176 (suppl 8):S1-S13.
  • 10Astrup A,R(o)ssner S,Van Gaal L,et al.Effects of liraglutide in the treatment of obesity:a randomised,double-blind,placebo-controlled study.Lancet,2009,374:1606-1616.

共引文献576

同被引文献52

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部